We are live on
!
Find out more
CWP
Corepath Wealth Partners Portfolio holdings
AUM
$160M
1-Year Est. Return
23.57%
This Fund
S&P 500
This Quarter
Est. Return
-1.58%
1 Year Est. Return
+23.57%
3 Year Est. Return
+55.96%
5 Year Est. Return
+46.74%
10 Year Est. Return
–
AUM
$130M
AUM Growth
+$1.07M
(+0.83%)
Cap. Flow
+$3.97M
Cap. Flow
% of AUM
3.05%
Top 10 Holdings %
Top 10 Hldgs %
81.78%
Holding
40
New
2
Increased
16
Reduced
4
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$821K |
| 2 |
iShares TIPS Bond ETF
TIP
|
+$579K |
| 3 |
iShares Core S&P US Value ETF
IUSV
|
+$473K |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$467K |
| 5 |
iShares Core US Aggregate Bond ETF
AGG
|
+$379K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fate Therapeutics
FATE
|
+$215K |
| 2 |
Target
TGT
|
+$140K |
| 3 |
VictoryShares US EQ Income Enhanced Volatility Wtd ETF
CDC
|
+$16K |
| 4 |
iShares Core S&P Small-Cap ETF
IJR
|
+$5.17K |
| 5 |
iShares S&P 500 Growth ETF
IVW
|
+$2.67K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 0.94% |
| 2 | Industrials | 0.32% |
| 3 | Healthcare | 0.22% |
| 4 | Consumer Staples | 0.21% |
Similar funds
RB
MWM
CF
TA
PCC
SGCM
TPW
RCWM
Corepath Wealth Partners's Q3 2021 Portfolio in Review
As of Q3 2021, Corepath Wealth Partners held 40 positions worth $130M, up 0.83% from $129M the previous quarter. Its ten largest holdings account for 82% of the portfolio.
Corepath Wealth Partners deployed $3.97M of net new capital in Q3 2021, opening 2 new positions and adding to 16 existing holdings.
By sector, the portfolio is most concentrated in Technology at 0.94% of assets, down from 0.96% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was Target, an estimated $140K trimmed.
- Corepath Wealth Partners added most to iShares Core S&P 500 ETF in Q3 2021, an estimated $821K increase.
- Corepath Wealth Partners's biggest Q3 2021 reduction was Target, cutting an estimated $140K.
- Corepath Wealth Partners fully exited Fate Therapeutics in Q3 2021, selling an estimated $215K.
- Corepath Wealth Partners's ten largest holdings make up 82% of its $130M portfolio in Q3 2021.
- Corepath Wealth Partners opened 2 new positions and closed 1 in Q3 2021.
- Corepath Wealth Partners's portfolio value rose 0.83% quarter-over-quarter to $130M.
Based on Corepath Wealth Partners's 13F filing for Q3 2021, filed 13 Oct 2021.